Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $844.8800 (3.78%) ($844.8800 - $846.2450) on Mon. Aug. 21, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.77% (three month average) | RSI | 84 | Latest Price | $844.8800(3.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.9% a day on average for past five trading days. | Weekly Trend | REGN advances 3.5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XLV(62%) IBB(60%) DIA(48%) XLF(48%) SPY(47%) | Factors Impacting REGN price | REGN will decline at least -0.885% in a week (0% probabilities). VXX(-44%) VIXM(-39%) TBT(-15%) USO(-14%) UUP(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.885% (StdDev 1.77%) | Hourly BBV | 1.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $812.01(4.05%) | 10 Day Moving Average | $804.21(5.06%) | 20 Day Moving Average | $777.4(8.68%) | To recent high | 0% | To recent low | 22% | Market Cap | $89.581b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |